CTLA4 and urinary bladder carcinoma: Excepting chemotherapy, immunotherapy is another important treatment for bladder cancer; in our study, we found that anti-CTLA4 and anti-PD1 were sensitive to patients with high-risk score of bladder cancer no matter whether used separately or in combination.